Delivery Order SPE2DB22D2206-SPE2DB24FEP46
- Not listed
- This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH6TN, was granted by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $34,372.17 and a completion date of November 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FN0W0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $91,134.36, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order and has a performance period ending on March 19, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award, valued at $42,465.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FF3ZC, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $10,445.69 and an ultimate completion date of March 11, 2024. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation,...
- This federal contract award, with an identifier of SPE2DB20D1100|SPE2DB25FZ66N, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $80,348.79. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2024. The contract is not designated as a set-aside....
- This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVAXR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $64,105.11 firm-fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key...
- This federal contract award, valued at $111,139.46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to support military healthcare programs. This is a Firm Fixed Price Delivery Order contract with a period of performance through May 30, 2024. The contract is not designated...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $10,229.24 and a completion date of July 22, 2024. This is a delivery order contract with a firm fixed price pricing type, and there is no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime...
- This federal contract award, SPE2DB22D2007|SPE2DB25FH8LB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $29,033.62 with a firm fixed price. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award, with identification number SPE2DB20D1047|SPE2DB24FF89F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIKTARVY 50-200-25 mg tablets. The contract has a firm fixed-price pricing type and a total ceiling value of $97,171.28. It is a delivery order contract with an ultimate completion date of September 24, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEP46Delivery Order
This federal contract award, identified as SPE2DB22D2206|SPE2DB24FEP46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $40,788.78. This is a Firm Fixed Price Delivery Order contract with a period of performance through December 12, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 12/11/23 |